Dr Reddy’s Launches Generic Version Of Vimovo
Hyderabad, Feb.27 (Maxim News): Dr. Reddy’s Laboratories Ltd. announced first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo (Naproxen and Esomeprazole Magnesium) approved by the U.S. Food and Drug Administration (USFDA).
“This launch is a testament to our core strengths in areas of research and development and intellectual property,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s said. “We are excited to be a part of forming the first generic market for Vimovo Tablets and to provide an affordable treatment alternative for patients.”
The Vimovo brand had U.S. sales of approximately $414 million for the 12, months ended December 2019 according to IQVIA Health. (Maxim News)